Cargando…
Importance of Inclusion of Pregnant and Breastfeeding Women in COVID-19 Therapeutic Trials
Investigators are employing unprecedented innovation in the design of clinical trials to rapidly and rigorously assess potentially promising therapies for coronavirus disease 2019 (COVID-19); this is in stark contrast to the continued near-universal regressive practice of exclusion of pregnant and b...
Autores principales: | LaCourse, Sylvia, John-Stewart, Grace, Adams Waldorf, Kristina M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184504/ https://www.ncbi.nlm.nih.gov/pubmed/32296817 http://dx.doi.org/10.1093/cid/ciaa444 |
Ejemplares similares
-
TB prevention strategies and unanswered questions for pregnant and postpartum women living with HIV: the need for improved evidence
por: Mathad, Jyoti S, et al.
Publicado: (2020) -
Importance of Prospective Studies in Pregnant and Breastfeeding Women Living With Human Immunodeficiency Virus
por: Colbers, Angela, et al.
Publicado: (2019) -
Coronavirus Disease 2019 (COVID-19) Pharmacologic Treatments for Children: Research Priorities and Approach to Pediatric Studies
por: Garcia-Prats, Anthony J, et al.
Publicado: (2020) -
Scabies-infested pregnant women: A critical therapeutic challenge
por: Weill, Amandine, et al.
Publicado: (2021) -
1344. Interferon Gamma Release Assay (IGRA) Responses in HIV-Infected and -Uninfected Women in Pregnancy
por: Kaplan, Samantha, et al.
Publicado: (2019)